CCI Photonics
Spin-out from Lancaster University (est. June 2023) developing a portable point-of-care diagnostic platform to rapidly identify pathogens and antimicrobial resistance (AMR). Activities include device prototyping, biological spectral database curation, AI model development, laboratory validation, and partnerships with academic and clinical institutions to progress toward clinical adoption and market approval.
Industries
Nr. of Employees
small (1-50)
Products
Portable point-of-care diagnostic device (β-prototype) for rapid AMR detection
A beta prototype portable diagnostic instrument that uses spectral data and AI models to detect pathogens and antimicrobial resistance from in-vitro and biofluid samples, aiming for rapid results.
Portable point-of-care diagnostic device (β-prototype) for rapid AMR detection
A beta prototype portable diagnostic instrument that uses spectral data and AI models to detect pathogens and antimicrobial resistance from in-vitro and biofluid samples, aiming for rapid results.
Services
Prototype validation and feasibility studies
Laboratory-based validation and feasibility testing of diagnostic prototypes in collaboration with research partners.
Collaborative research partnerships
Partnerships with universities and clinical research bodies to support development, testing, and validation of diagnostics.
Prototype validation and feasibility studies
Laboratory-based validation and feasibility testing of diagnostic prototypes in collaboration with research partners.
Collaborative research partnerships
Partnerships with universities and clinical research bodies to support development, testing, and validation of diagnostics.
Expertise Areas
- Point-of-care diagnostics
- Antimicrobial resistance detection
- Spectral data analytics for biological samples
- AI-driven diagnostic model development
Key Technologies
- Spectral analysis for biological samples
- Biological spectral databases
- Machine learning / AI for diagnostics
- Portable point-of-care hardware